​

Tenet Healthcare (THC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

THC Stock Forecast

Tenet Healthcare stock forecast is as follows: an average price target of $161.50 (represents a 24.75% upside from THC’s last price of $129.46) and a rating consensus of 'Buy', based on 13 wall street analysts offering a 1-year stock forecast.

THC Price Target

The average price target for Tenet Healthcare (THC) is $161.50 based on 1-year price targets from 13 Wall Street analysts in the past 3 months, with a price target range of $178.00 to $140.00. This represents a potential 24.75% upside from THC's last price of $129.46.

THC Analyst Ratings

Buy

According to 13 Wall Street analysts, Tenet Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for THC stock is 1 'Strong Buy' (7.69%), 11 'Buy' (84.62%), 1 'Hold' (7.69%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Tenet Healthcare Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 16, 2024Jamie PerseGoldman Sachs$140.00$139.100.65%8.14%
Oct 29, 2024Justin LakeWolfe Research$178.00$156.2013.96%37.49%
Jul 26, 2024Ann HynesMizuho Securities$170.00$151.6312.12%31.31%
Jul 25, 2024David MacDonaldTruist Financial$170.00$147.6815.11%31.31%
Jul 15, 2024David MacDonaldTruist Financial$155.00$132.1117.32%19.73%
Jul 10, 2024Andrew MokBarclays$156.00$130.9719.11%20.50%
Jun 28, 2024Pito ChickeringDeutsche Bank$155.00$138.3012.08%19.73%
Jun 10, 2024Jamie PerseGoldman Sachs$156.00$136.4014.37%20.50%
May 30, 2024Pito ChickeringDeutsche Bank$150.00$131.5514.03%15.87%
May 29, 2024Michael HaRobert W. Baird$153.00$131.5516.31%18.18%
May 02, 2024Andrew MokBarclays$147.00$115.9526.78%13.55%
May 01, 2024Scott FidelStephens$122.00$112.298.65%-5.76%
May 01, 2024Ann HynesMizuho Securities$130.00$115.4612.59%0.42%
May 01, 2024Ben HendrixRBC Capital$136.00$115.1118.15%5.05%
Apr 12, 2024Pito ChickeringDeutsche Bank$126.00$101.8223.75%-2.67%
Mar 27, 2024Justin LakeWolfe Research$122.00$102.3219.23%-5.76%
Jan 03, 2023Wells Fargo$59.00$48.9820.46%-54.43%
Oct 24, 2022Andrew Mok CFAUBS$47.00$39.0120.48%-63.70%
Aug 24, 2022Leerink Partners$93.00$61.3951.49%-28.16%
Aug 16, 2022Ann HynesMizuho Securities$80.00$64.9523.16%-38.20%
Jul 28, 2022UBS$91.00$64.2141.72%-29.71%
Jul 26, 2022Raymond James$67.50$31.37115.17%-47.86%
Jul 25, 2022RBC Capital$99.00$62.1859.22%-23.53%
Jul 25, 2022Truist Financial$80.00$62.9927.00%-38.20%
Jul 25, 2022Citigroup$99.00$64.8652.65%-23.53%
Jul 25, 2022Leerink Partners$88.00$63.1239.42%-32.03%
Jul 15, 2022Leerink Partners$68.00$53.4327.27%-47.47%
Jul 12, 2022Goldman Sachs$93.00$54.1571.75%-28.16%
Jul 11, 2022Raymond James$55.00$27.5799.49%-57.52%
Jul 07, 2022Deutsche Bank$90.00$53.3368.76%-30.48%
Jul 01, 2022Mizuho Securities$63.00$52.5619.86%-51.34%
Apr 25, 2022Wells Fargo$90.00$75.2919.54%-30.48%
Apr 22, 2022Deutsche Bank$110.00$76.3844.02%-15.03%
Apr 22, 2022Citigroup$110.00$74.8546.96%-15.03%
Apr 22, 2022Barclays$104.00$79.7830.36%-19.67%
Apr 22, 2022Leerink Partners$110.00$79.8937.70%-15.03%
Apr 22, 2022RBC Capital$104.00$86.6720.00%-19.67%
Feb 09, 2022Whit MayoLeerink Partners$100.00$82.2221.62%-22.76%
Feb 09, 2022Ben HendrixRBC Capital$89.00$82.228.25%-31.25%
Feb 08, 2022Pito ChickeringDeutsche Bank$100.00$74.0735.01%-22.76%
Jan 20, 2022John RansomRaymond James$120.00$78.4253.02%-7.31%
Jan 10, 2022Jason CassorlaCitigroup$96.00$74.5528.77%-25.85%
Jan 07, 2022Kevin FischbeckBank of America Securities$100.00$74.8833.55%-22.76%
Jun 21, 2021Justin LakeWolfe Research$70.00$68.582.07%-45.93%

The latest Tenet Healthcare stock forecast, released on Dec 16, 2024 by Jamie Perse from Goldman Sachs, set a price target of $140.00, which represents a 0.65% increase from the stock price at the time of the forecast ($139.10), and a 8.14% increase from THC last price ($129.46).

Tenet Healthcare Price Target by Period

1M3M12M
# Anlaysts1216
Avg Price Target$140.00$159.00$147.88
Last Closing Price$129.46$129.46$129.46
Upside/Downside8.14%22.82%14.23%

In the current month, the average price target of Tenet Healthcare stock is $140.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 8.14% increase as opposed to Tenet Healthcare's last price of $129.46. This month's average price target is down -11.95% compared to last quarter, and down -5.33% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 16, 2024Goldman SachsBuyNeutralDowngrade
Oct 30, 2024Cantor FitzgeraldOverweightOverweightHold
Oct 30, 2024UBSBuyBuyHold
Oct 29, 2024Wolfe ResearchOutperformOutperformHold
Oct 22, 2024UBSUnderperformUnderperformHold
Oct 22, 2024Wells FargoBuyBuyHold
Oct 10, 2024KeyBancOverweightInitialise
Oct 01, 2024Wells FargoBuyBuyHold
Aug 14, 2024Wells FargoBuyBuyHold
Aug 14, 2024UBSUnderperformUnderperformHold
Jul 30, 2024Wells FargoOverweightOverweightHold
Jul 25, 2024Truist FinancialUnderperformUnderperformHold
Jul 25, 2024UBSBuyBuyHold
Jul 25, 2024Raymond JamesStrong BuyStrong BuyHold
Jul 25, 2024Cantor FitzgeraldOverweightOverweightHold
Jul 25, 2024CitigroupBuyBuyHold
Jul 10, 2024BarclaysOverweightOverweightHold
Jul 02, 2024StephensUnderperformUnderperformHold
Jul 02, 2024UBSBuyBuyHold
Jun 28, 2024Deutsche BankBuyBuyHold
Jun 10, 2024Goldman SachsBuyBuyHold
May 30, 2024Wolfe ResearchBuyBuyHold
May 30, 2024Wells FargoUnderperformUnderperformHold
May 30, 2024Deutsche BankBuyBuyHold
May 02, 2024BarclaysOverweightOverweightHold
May 01, 2024StephensEqual-WeightEqual-WeightHold
May 01, 2024RBC CapitalOutperformOutperformHold
Apr 12, 2024Deutsche BankBuyBuyHold
Mar 27, 2024Wolfe ResearchBuyBuyHold
Mar 27, 2024Wells FargoUnderperformUnderperformHold
Mar 27, 2024Wolfe ResearchOutperformUpgrade
Mar 05, 2024Wells FargoBuyBuyHold
Mar 05, 2024RBC CapitalUnderperformUnderperformHold
Feb 09, 2024JefferiesBuyBuyHold
Nov 01, 2023Raymond JamesStrong BuyStrong BuyHold
Oct 31, 2023RBC CapitalOutperformOutperformHold
Aug 01, 2023CitigroupBuyBuyHold
Aug 01, 2023UBSBuyBuyHold
Aug 01, 2023RBC CapitalOutperformOutperformHold
Aug 01, 2023StephensEqual-WeightEqual-WeightHold
Jan 03, 2023Wells FargoOverweightOverweightHold
Oct 24, 2022Wells FargoOverweightOverweightHold
Aug 24, 2022SVB LeerinkOutperformOutperformHold
Jul 28, 2022UBSBuyBuyHold
Jul 25, 2022RBC CapitalOutperformOutperformHold
Jul 25, 2022CitigroupBuyBuyHold
Jul 15, 2022SVB LeerinkOutperformOutperformHold
Jul 12, 2022Goldman SachsBuyBuyHold
Jul 11, 2022Raymond JamesStrong BuyStrong BuyHold
Jul 07, 2022Deutsche BankBuyBuyHold
Feb 10, 2022UBSBuyUpgrade

Tenet Healthcare's last stock rating was published by Goldman Sachs on Dec 16, 2024. The company Downgrade its THC rating from "Buy" to "Neutral".

Tenet Healthcare Financial Forecast

Tenet Healthcare Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$5.38B-$5.08B$5.02B$4.99B$4.80B$4.64B$4.75B$4.86B$4.89B$4.95B$4.78B$4.92B$4.56B$3.65B$4.52B$4.81B$4.57B
Avg Forecast$5.76B$5.53B$5.52B$5.43B$5.45B$5.30B$5.25B$5.30B$5.17B$5.05B$4.99B$5.15B$5.27B$5.02B$4.91B$4.84B$4.91B$4.81B$4.78B$4.71B$4.99B$4.83B$4.77B$4.76B$4.86B$4.39B$3.75B$4.63B$4.76B$4.46B
High Forecast$6.10B$5.85B$5.84B$5.74B$5.77B$5.61B$5.56B$5.65B$5.27B$5.06B$4.99B$5.15B$5.41B$5.32B$5.20B$5.12B$5.20B$4.81B$4.78B$4.71B$4.99B$4.83B$4.77B$4.76B$4.86B$4.39B$3.75B$4.63B$4.76B$4.46B
Low Forecast$5.57B$5.34B$5.33B$5.25B$5.27B$5.13B$5.08B$5.08B$5.11B$5.04B$4.99B$5.15B$5.21B$4.86B$4.75B$4.68B$4.75B$4.81B$4.78B$4.71B$4.99B$4.83B$4.77B$4.76B$4.86B$4.39B$3.75B$4.63B$4.76B$4.46B
# Analysts545443481153471111111111119991313
Surprise %------------1.02%-1.03%1.04%1.02%1.00%0.97%1.01%0.97%1.01%1.04%1.00%1.01%1.04%0.97%0.98%1.01%1.03%

Tenet Healthcare's average Quarter revenue forecast for Mar 24 based on 4 analysts is $5.15B, with a low forecast of $5.15B, and a high forecast of $5.15B. THC's average Quarter revenue forecast represents a -4.30% decrease compared to the company's last Quarter revenue of $5.38B (Dec 23).

Tenet Healthcare EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts545443481153471111111111119991313
EBITDA------------$-1.13B-$200.00M$830.00M$901.00M$847.00M$843.00M$888.00M$1.01B$862.00M$833.00M$787.00M$1.30B$551.00M$734.00M$586.00M$803.00M$627.00M
Avg Forecast$931.65M$893.14M$891.40M$877.07M$881.42M$856.98M$848.58M$856.07M$835.25M$815.98M$806.39M$702.80M$852.05M$812.05M$793.68M$638.91M$856.49M$815.35M$809.45M$505.07M$844.65M$818.81M$807.96M$372.52M$822.83M$743.28M$635.39M$835.20M$805.87M$754.70M
High Forecast$985.72M$944.98M$943.14M$927.97M$932.57M$906.71M$897.83M$912.82M$851.44M$817.45M$806.39M$843.36M$874.73M$859.18M$839.74M$766.69M$1.03B$815.35M$809.45M$606.08M$844.65M$818.81M$807.96M$447.02M$822.83M$743.28M$635.39M$1.00B$805.87M$754.70M
Low Forecast$900.83M$863.60M$861.91M$848.06M$852.26M$828.63M$820.51M$820.40M$825.54M$814.51M$806.39M$562.24M$842.33M$785.18M$767.42M$511.13M$685.19M$815.35M$809.45M$404.05M$844.65M$818.81M$807.96M$298.02M$822.83M$743.28M$635.39M$668.16M$805.87M$754.70M
Surprise %-------------1.32%-0.25%1.30%1.05%1.04%1.04%1.76%1.20%1.05%1.03%2.11%1.58%0.74%1.16%0.70%1.00%0.83%

1 analysts predict THC's average Quarter EBITDA for Sep 23 to be $812.05M, with a high of $859.18M and a low of $785.18M. This is 306.03% upper than Tenet Healthcare's previous annual EBITDA (Jun 23) of $200.00M.

Tenet Healthcare Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts545443481153471111111111119991313
Net Income------------$791.00M-$293.00M$296.00M$274.00M$268.00M$179.00M$279.00M$420.00M$449.00M$258.00M$222.00M$414.00M$-107.00M$169.00M$160.00M$129.00M$-153.00M
Avg Forecast$333.63M$295.02M$269.89M$325.85M$305.54M$266.47M$246.22M$301.91M$285.31M$228.59M$184.40M$147.07M$154.82M$115.58M$120.67M$133.70M$273.77M$122.35M$66.01M$105.69M$149.49M$101.12M$105.78M$59.63M$93.95M$31.76M$-70.26M$167.40M$96.91M$30.97M
High Forecast$358.80M$317.28M$290.25M$350.44M$328.59M$286.58M$264.80M$364.13M$351.23M$231.59M$184.93M$176.49M$172.46M$115.59M$123.38M$160.44M$328.52M$123.77M$66.01M$126.83M$149.49M$101.12M$108.90M$71.55M$93.95M$31.76M$-70.26M$200.88M$96.91M$30.97M
Low Forecast$319.28M$282.33M$258.28M$311.84M$292.40M$255.01M$235.63M$240.72M$257.07M$225.59M$183.88M$117.66M$140.12M$115.57M$117.95M$106.96M$219.01M$120.93M$66.01M$84.56M$149.49M$101.12M$102.67M$47.70M$93.95M$31.76M$-70.26M$133.92M$96.91M$30.97M
Surprise %------------5.11%-2.43%2.21%1.00%2.19%2.71%2.64%2.81%4.44%2.44%3.72%4.41%-3.37%-2.41%0.96%1.33%-4.94%

Tenet Healthcare's average Quarter net income forecast for Mar 24 is $147.07M, with a range of $117.66M to $176.49M. THC's average Quarter net income forecast represents a -81.41% decrease compared to the company's last Quarter net income of $791.00M (Dec 23).

Tenet Healthcare SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts545443481153471111111111119991313
SG&A------------$6.83B--$2.26B$2.31B$2.23B$2.13B$2.18B$2.19B$2.21B$2.28B$2.20B$2.23B$2.14B$1.86B$2.19B$2.23B$2.17B
Avg Forecast$2.66B$2.55B$2.55B$2.51B$2.52B$2.45B$2.43B$2.45B$2.39B$2.33B$2.31B$2.29B$2.44B$2.32B$2.27B$2.08B$2.41B$2.22B$2.21B$1.65B$2.30B$2.23B$2.20B$1.35B$2.24B$2.03B$1.73B$3.94B$2.20B$2.06B
High Forecast$2.82B$2.70B$2.70B$2.65B$2.67B$2.59B$2.57B$2.61B$2.43B$2.34B$2.31B$2.75B$2.50B$2.46B$2.40B$2.50B$2.89B$2.22B$2.21B$1.98B$2.30B$2.23B$2.20B$1.62B$2.24B$2.03B$1.73B$4.72B$2.20B$2.06B
Low Forecast$2.58B$2.47B$2.46B$2.42B$2.44B$2.37B$2.35B$2.35B$2.36B$2.33B$2.31B$1.83B$2.41B$2.24B$2.19B$1.67B$1.92B$2.22B$2.21B$1.32B$2.30B$2.23B$2.20B$1.08B$2.24B$2.03B$1.73B$3.15B$2.20B$2.06B
Surprise %------------2.80%--1.08%0.96%1.00%0.96%1.32%0.95%0.99%1.03%1.63%0.99%1.06%1.08%0.56%1.01%1.06%

Tenet Healthcare's average Quarter SG&A projection for Mar 24 is $2.29B, based on 4 Wall Street analysts, with a range of $1.83B to $2.75B. The forecast indicates a -66.44% fall compared to THC last annual SG&A of $6.83B (Dec 23).

Tenet Healthcare EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts545443481153471111111111119991313
EPS------------$0.01-$2.88$2.89$2.62$2.48$1.66$2.60$3.92$4.19$2.42$2.09$3.92$-1.02$1.61$1.53$1.24$-1.48
Avg Forecast$3.45$3.05$2.79$3.37$3.16$2.76$2.55$3.12$2.95$2.37$1.91$1.45$1.60$1.20$1.25$1.16$1.23$1.24$0.67$1.08$1.52$1.03$1.07$0.76$0.95$0.32$-0.71$0.29$0.98$0.31
High Forecast$3.71$3.28$3.00$3.63$3.40$2.97$2.74$3.77$3.63$2.40$1.91$1.51$1.78$1.20$1.28$1.24$1.32$1.26$0.67$1.08$1.52$1.03$1.11$0.76$0.95$0.32$-0.71$0.29$0.98$0.31
Low Forecast$3.30$2.92$2.67$3.23$3.03$2.64$2.44$2.49$2.66$2.33$1.90$1.39$1.45$1.20$1.22$1.11$1.18$1.23$0.67$1.08$1.52$1.03$1.04$0.76$0.95$0.32$-0.71$0.29$0.98$0.31
Surprise %------------0.00%-2.31%2.50%2.13%2.00%2.48%2.42%2.58%4.08%2.25%2.76%4.11%-3.16%-2.26%5.35%1.26%-4.70%

According to 4 Wall Street analysts, Tenet Healthcare's projected average Quarter EPS for Mar 24 is $1.45, with a low estimate of $1.39 and a high estimate of $1.51. This represents a 18524.10% increase compared to THC previous annual EPS of $0.01 (Dec 23).

Tenet Healthcare Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
SEMSelect Medical$19.12$40.00109.21%Buy
AMNAMN Healthcare Services$24.47$51.00108.42%Buy
ACHCAcadia Healthcare Company$39.64$81.50105.60%Buy
INNVInnovAge$4.08$6.8066.67%Hold
SGRYSurgery Partners$21.03$35.0066.43%Buy
BKDBrookdale Senior Living$5.25$8.0052.38%Buy
HCAHCA Healthcare$307.78$423.2037.50%Buy
UHSUniversal Health Services$182.60$249.6736.73%Hold
THCTenet Healthcare$132.55$161.5021.84%Buy
PNTGPennant Group$29.21$34.6718.69%Buy
ENSGEnsign Group$140.00$159.0013.57%Buy
ADUSAddus HomeCare$130.73$146.2011.83%Buy
EHCEncompass Health$96.94$107.5010.89%Buy
DVADaVita$147.57$145.00-1.74%Hold

THC Forecast FAQ

Is Tenet Healthcare a good buy?

Yes, according to 13 Wall Street analysts, Tenet Healthcare (THC) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 11 'Buy' recommendations, accounting for 92.31% of THC's total ratings.

What is THC's price target?

Tenet Healthcare (THC) average price target is $161.5 with a range of $140 to $178, implying a 24.75% from its last price of $129.46. The data is based on 13 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Tenet Healthcare stock go up soon?

According to Wall Street analysts' prediction for THC stock, the company can go up by 24.75% (from the last price of $129.46 to the average price target of $161.5), up by 37.49% based on the highest stock price target, and up by 8.14% based on the lowest stock price target.

Can Tenet Healthcare stock reach $200?

THC's average twelve months analyst stock price target of $161.5 does not support the claim that Tenet Healthcare can reach $200 in the near future.

What is Tenet Healthcare's current price target trend?

1 Wall Street analyst forecast a $140 price target for Tenet Healthcare (THC) this month, up 8.14% from its last price of $129.46. Compared to the last 3 and 12 months, the average price target increased by 22.82% and increased by 14.23%, respectively.

What are Tenet Healthcare's analysts' financial forecasts?

Tenet Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $21.3B (high $22.58B, low $20.55B), average EBITDA is $3.44B (high $3.65B, low $3.32B), average net income is $1.12B (high $1.24B, low $1.02B), average SG&A $9.84B (high $10.43B, low $9.5B), and average EPS is $11.59 (high $12.87, low $10.59). THC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $22.23B (high $23.52B, low $21.5B), average EBITDA is $3.59B (high $3.8B, low $3.47B), average net income is $1.22B (high $1.32B, low $1.17B), average SG&A $10.27B (high $10.87B, low $9.93B), and average EPS is $12.67 (high $13.62, low $12.12).

Did the THC's actual financial results beat the analysts' financial forecasts?

Based on Tenet Healthcare's last annual report (Dec 2023), the company's revenue was $20.55B, beating the average analysts forecast of $20.05B by 2.48%. Apple's EBITDA was $974M, missing the average prediction of $3.1B by -68.55%. The company's net income was $1.31B, beating the average estimation of $524.77M by 149.82%. Apple's SG&A was $0, missing the average forecast of $9.11B by -100.00%. Lastly, the company's EPS was $0.0129, missing the average prediction of $5.2 by -99.75%. In terms of the last quarterly report (Dec 2023), Tenet Healthcare's revenue was $5.38B, beating the average analysts' forecast of $5.27B by 2.03%. The company's EBITDA was $-1.127B, missing the average prediction of $852.05M by -232.27%. Tenet Healthcare's net income was $791M, beating the average estimation of $154.82M by 410.91%. The company's SG&A was $6.83B, beating the average forecast of $2.44B by 180.44%. Lastly, the company's EPS was $0.0078, missing the average prediction of $1.6 by -99.51%